Literature DB >> 30868345

Acceptance of a propofol and remifentanil infusion dosing algorithm to optimize postoperative emergence and analgesia.

Carl Tams1, Ken Johnson2, Christoph Seubert3.   

Abstract

We implemented a pharmacokinetic/pharmacodynamic (PK/PD) based optimization algorithm recommending intraoperative Remifentanil and Propofol infusion rates to minimize time to emergence and maximize the duration of analgesia in a clinical setting. This feasibility study tested the clinical acceptance of the optimization algorithm's recommendations during scoliosis surgical repair for 14 patients. Anesthesiologist accepted 359/394 (91%) of the recommendations given on the basis of the optimization algorithm. While following the optimization's recommendations the anesthesiologist decreased Propofol infusions from an average of 164-135 mcg/kg/min [p = 0.002] and increased Remifentanil infusions from an average of 0.22-0.30 mcg/kg/min [p = 0.004]. The anesthesiologists appeared to accept and follow the recommendations from a PK/PD based optimization algorithm.

Entities:  

Keywords:  Anesthesia; Idiopathic scoliosis; Optimization; Pharmacodynamic; Pharmacokinetic; Total intravenous anesthesia

Mesh:

Substances:

Year:  2019        PMID: 30868345     DOI: 10.1007/s10877-019-00295-y

Source DB:  PubMed          Journal:  J Clin Monit Comput        ISSN: 1387-1307            Impact factor:   2.502


  11 in total

Review 1.  Equianalgesic dose ratios for opioids. a critical review and proposals for long-term dosing.

Authors:  J Pereira; P Lawlor; A Vigano; M Dorgan; E Bruera
Journal:  J Pain Symptom Manage       Date:  2001-08       Impact factor: 3.612

2.  Equianalgesic dosing of opioids.

Authors:  Hildegarde J Berdine; Suzanne A Nesbit
Journal:  J Pain Palliat Care Pharmacother       Date:  2006

Review 3.  Optimizing intravenous drug administration by applying pharmacokinetic/pharmacodynamic concepts.

Authors:  M M R F Struys; M Sahinovic; B J Lichtenbelt; H E M Vereecke; A R Absalom
Journal:  Br J Anaesth       Date:  2011-05-30       Impact factor: 9.166

4.  A Rapid Recovery Pathway for Adolescent Idiopathic Scoliosis That Improves Pain Control and Reduces Time to Inpatient Recovery After Posterior Spinal Fusion.

Authors:  Alex L Gornitzky; John M Flynn; Wallis T Muhly; Wudbhav N Sankar
Journal:  Spine Deform       Date:  2016-06-16

Review 5.  Propofol: a review of its role in pediatric anesthesia and sedation.

Authors:  Vidya Chidambaran; Andrew Costandi; Ajay D'Mello
Journal:  CNS Drugs       Date:  2015-07       Impact factor: 5.749

Review 6.  Model-based drug administration: current status of target-controlled infusion and closed-loop control.

Authors:  Merel H Kuizenga; Hugo E M Vereecke; Michel M R F Struys
Journal:  Curr Opin Anaesthesiol       Date:  2016-08       Impact factor: 2.706

7.  Navigator® and SmartPilot® View are helpful in guiding anesthesia and reducing anesthetic drug dosing.

Authors:  V Cirillo; G Zito Marinosci; E De Robertis; C Iacono; G M Romano; O Desantis; O Piazza; G Servillo; R Tufano
Journal:  Minerva Anestesiol       Date:  2015-01-19       Impact factor: 3.051

8.  Pharmacokinetics and pharmacodynamics of remifentanil. II. Model application.

Authors:  C F Minto; T W Schnider; S L Shafer
Journal:  Anesthesiology       Date:  1997-01       Impact factor: 7.892

9.  Intraoperative methadone improves postoperative pain control in patients undergoing complex spine surgery.

Authors:  Antje Gottschalk; Marcel E Durieux; Edward C Nemergut
Journal:  Anesth Analg       Date:  2010-04-24       Impact factor: 5.108

Review 10.  Methadone for cancer pain.

Authors:  A B Nicholson
Journal:  Cochrane Database Syst Rev       Date:  2007-10-17
View more
  2 in total

1.  Administration of anesthetic drugs according to pharmacological principles: are we heading in the right direction?

Authors:  Hugo E M Vereecke
Journal:  J Clin Monit Comput       Date:  2019-08-16       Impact factor: 2.502

Review 2.  End of year summary 2019: anaesthesia and airway management.

Authors:  Jan F A Hendrickx; Tom Van Zundert; Andre M De Wolf
Journal:  J Clin Monit Comput       Date:  2020-01-02       Impact factor: 2.502

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.